Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C099630 |
3-((4-(4-chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine |
3-((4-(4-chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine binds to and results in decreased activity of DRD4 protein | affects binding|decreases activity | 16415089
|
C099630 |
3-((4-(4-chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine |
[3-((4-(4-chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine binds to and results in decreased activity of DRD4 protein] which results in increased activity of DDC protein | affects binding|decreases activity|increases activity | 16415089
|
C099630 |
3-((4-(4-chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine |
3-((4-(4-chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo(2,3-b)pyridine binds to and results in decreased activity of DRD4 protein | affects binding|decreases activity | 15729293
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of DRD4 mRNA | affects expression | 16483693
|
C006780 |
bisphenol A |
bisphenol A results in decreased expression of DRD4 mRNA | decreases expression | 15079872
|
D004390 |
Chlorpyrifos |
Chlorpyrifos affects the expression of DRD4 mRNA | affects expression | 18812211 17452286
|
D003024 |
Clozapine |
Clozapine binds to DRD4 protein | affects binding | 11997696
|
D003024 |
Clozapine |
DRD4 gene polymorphism affects the susceptibility to Clozapine | affects response to substance | 16223700
|
D003024 |
Clozapine |
Clozapine analog binds to DRD4 protein | affects binding | 11997696
|
D003976 |
Diazinon |
Diazinon affects the expression of DRD4 mRNA | affects expression | 17452286
|
D004026 |
Dieldrin |
Dieldrin results in decreased expression of DRD4 mRNA | decreases expression | 18812211
|
D004051 |
Diethylhexyl Phthalate |
Diethylhexyl Phthalate results in decreased expression of DRD4 mRNA | decreases expression | 15518916
|
D004298 |
Dopamine |
DRD4 protein affects the reaction [Dopamine binds to DRD2 protein] | affects binding|affects reaction | 15716360
|
D005419 |
Flavonoids |
Flavonoids results in increased expression of DRD4 mRNA | increases expression | 18035473
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of DRD4 mRNA | affects cotreatment|increases expression | 17183730
|
D016627 |
Oxidopamine |
Oxidopamine results in increased expression of DRD4 mRNA | increases expression | 15303306
|
D008694 |
Methamphetamine |
DRD4 gene polymorphism affects the susceptibility to Methamphetamine | affects response to substance | 19462300
|
D009020 |
Morphine |
Morphine results in increased expression of DRD4 mRNA | increases expression | 15183518
|
D010269 |
Paraquat |
Paraquat affects the expression of DRD4 mRNA | affects expression | 15206577
|
D010852 |
Picrotoxin |
Picrotoxin results in increased expression of DRD4 mRNA | increases expression | 15170462
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of DRD4 mRNA | affects cotreatment|increases expression | 17183730
|
C025643 |
vinclozolin |
vinclozolin results in increased expression of DRD4 mRNA | increases expression | 15686871
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Diethylhexyl Phthalate |
8.83 | 6734493 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
8.83 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.89 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.52 | 18287403 |
MESH:D000380 |
Agranulocytosis |
|
Clozapine |
5.02 | 12649775 14617031 16160616 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Chlorpyrifos |
14.36 | 16611668 17119214 11874814 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Diazinon |
14.36 | 16487989 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Paraquat |
14.36 | 11874814 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.20 | 17688650 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
8.73 | 17497229 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
8.73 | 19015723 |
MESH:D001010 |
Anxiety, Separation |
marker/mechanism |
|
| 20731709 |
MESH:D019958 |
Attention Deficit and Disruptive Behavior Disorders |
marker/mechanism |
|
| 20731709 |
MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
marker/mechanism |
|
| 14699433 |
MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
|
Oxidopamine |
4.62 | 14699433 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.01 | 20603192 18940202 17507914 17157402 18316065 19232924 15238991 18396377 18775368 19460635 18558336 17688650 18177632 16609825 18985861 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.05 | 20046352 17594078 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.37 | 8888407 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.82 | 11985600 |
MESH:D002545 |
Brain Ischemia |
|
Morphine |
5.11 | 19211983 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
2.66 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Dieldrin |
2.66 | 11859874 15770527 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.95 | 17123778 |
MESH:D002659 |
Child Development Disorders, Pervasive |
marker/mechanism |
|
| 20731709 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.69 | 20734317 |
MESH:D003072 |
Cognition Disorders |
|
Clozapine |
4.92 | 17123785 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
1.89 | 8888407 16575769 17688650 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.30 | 14966744 |
MESH:D003876 |
Dermatitis, Atopic |
|
Diethylhexyl Phthalate |
4.03 | 16882537 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Clozapine |
2.96 | 16402076 |
MESH:D003967 |
Diarrhea |
|
Morphine |
4.48 | 2540324 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Clozapine |
5.53 | 15331141 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
2.16 | 1733752 19641884 |
MESH:D050171 |
Dyslipidemias |
|
Clozapine |
4.15 | 16402076 |
MESH:D004417 |
Dyspnea |
|
Diazinon |
4.77 | 16487989 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.01 | 1851702 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.11 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.89 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.91 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.55 | 6254150 6426943 7562514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.26 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.03 | 3659116 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
3.26 | 14986274 19224547 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.86 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.09 | 8888407 18558336 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
4.90 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.27 | 16417039 |
MESH:D005911 |
Gliosis |
|
Paraquat |
5.14 | 11124998 |
MESH:D006505 |
Hepatitis |
|
Diazinon |
4.53 | 16487989 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.83 | 17688650 |
MESH:D006948 |
Hyperkinesis |
|
Clozapine |
11.71 | 16046005 |
MESH:D006948 |
Hyperkinesis |
|
Methamphetamine |
11.71 | 17658665 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.59 | 16612254 |
MESH:D007022 |
Hypotension |
|
Dopamine |
4.98 | 6740701 |
MESH:D007247 |
Infertility, Female |
|
Dieldrin |
4.90 | 10630421 |
MESH:D007248 |
Infertility, Male |
|
Diazinon |
11.25 | 12948887 16466525 |
MESH:D007248 |
Infertility, Male |
|
Paraquat |
11.25 | 4850670 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
11.25 | 16467254 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
2.63 | 17296493 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
3.26 | 16393666 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.14 | 17596541 16294345 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.70 | 16417039 |
MESH:D008064 |
Lipidoses |
|
Clozapine |
3.93 | 17567588 |
MESH:D008107 |
Liver Diseases |
|
Chlorpyrifos |
3.06 | 15991261 |
MESH:D008113 |
Liver Neoplasms |
|
Dieldrin |
5.39 | 9539021 8742319 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylhexyl Phthalate |
5.39 | 11940454 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.23 | 17228818 |
MESH:D001523 |
Mental Disorders |
|
Clozapine |
3.91 | 16856516 |
MESH:D024821 |
Metabolic Syndrome X |
|
Clozapine |
4.37 | 19142101 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.16 | 18765137 18803445 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.99 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.13 | 17596541 |
MESH:D009369 |
Neoplasms |
|
Dieldrin |
3.45 | 8820588 |
MESH:D009410 |
Nerve Degeneration |
|
Paraquat |
3.68 | 16893418 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
3.93 | 11399458 16427766 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.10 | 8888407 16359493 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Oxidopamine |
4.72 | 18514411 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Chlorpyrifos |
4.14 | 15081274 |
OMIM:601696 |
NOVELTY SEEKING PERSONALITY TRAIT |
marker/mechanism |
|
| |
MESH:D009765 |
Obesity |
|
Clozapine |
3.01 | 18515891 19142110 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.95 | 11985600 |
MESH:D010146 |
Pain |
|
Morphine |
4.15 | 15275824 20225289 15215642 16273134 6776300 18699797 |
MESH:D010300 |
Parkinson Disease |
marker/mechanism |
|
| |
MESH:D010300 |
Parkinson Disease |
|
Dieldrin |
5.73 | 16112328 11181820 11445065 17291500 16809432 |
MESH:D010300 |
Parkinson Disease |
|
Paraquat |
5.73 | 15824117 11445065 15451049 12911755 11124998 16140633 16510128 11181820 |
MESH:D010302 |
Parkinson Disease, Secondary |
|
Oxidopamine |
11.26 | 15893579 11771942 |
MESH:D010302 |
Parkinson Disease, Secondary |
|
Paraquat |
11.26 | 16190885 |
MESH:D011014 |
Pneumonia |
|
Paraquat |
4.42 | 12504350 |
MESH:D011041 |
Poisoning |
|
Diazinon |
4.31 | 17603234 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
16.14 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
16.14 | 20603192 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
16.14 | 18220299 19015723 18042343 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
4.90 | 18220299 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.17 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
3.42 | 16740699 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
4.90 | 18629315 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.51 | 11422049 12752131 |
MESH:D011618 |
Psychotic Disorders |
|
Clozapine |
4.15 | 15331141 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.75 | 10548101 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Paraquat |
2.90 | 16324872 17997886 |
MESH:D015427 |
Reperfusion Injury |
|
Morphine |
4.11 | 19211983 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Paraquat |
3.86 | 11700416 |
MESH:D012135 |
Respiratory Sounds |
|
Chlorpyrifos |
9.81 | 11874814 17119214 16611668 |
MESH:D012135 |
Respiratory Sounds |
|
Paraquat |
9.81 | 11874814 |
MESH:D012140 |
Respiratory Tract Diseases |
|
Chlorpyrifos |
4.86 | 16611668 17119214 |
MESH:D012162 |
Retinal Degeneration |
|
Paraquat |
3.83 | 16458197 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.13 | 19155313 |
MESH:D012559 |
Schizophrenia |
marker/mechanism |
|
| 18583979 |
MESH:D012559 |
Schizophrenia |
|
Clozapine |
3.81 | 17123785 20521326 16141801 11763009 17667964 17726453 18806925 18855531 11151749 20107430 19369910 20580759 20168265 20521320 20452607 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
3.81 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Picrotoxin |
6.38 | 8635557 8954991 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
6.38 | 1511512 15475178 16876388 17978042 14763951 11738929 3137016 11044598 |
MESH:D012729 |
Sex Chromosome Aberrations |
|
Chlorpyrifos |
6.06 | 6418539 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.75 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.51 | 12833885 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.95 | 16684133 16045194 |
MESH:D013981 |
Tic Disorders |
marker/mechanism |
|
| 20731709 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.20 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.49 | 3119515 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.60 | 8888407 |
MESH:D014570 |
Urologic Diseases |
|
Diazinon |
5.25 | 16487989 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.98 | 14652134 |
MESH:D015430 |
Weight Gain |
|
Clozapine |
4.43 | 16141801 20107430 16402076 17502770 20564506 20521320 |
MESH:D015431 |
Weight Loss |
|
Clozapine |
5.04 | 17933447 |